Matches in Nanopublications for { ?s ?p "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP383909.RA1hgkzWS2BejiNKeqwWUd7WXLoF447_O47oQvQeNc8t0130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383909.RA1hgkzWS2BejiNKeqwWUd7WXLoF447_O47oQvQeNc8t0130_provenance.
- NP82364.RAQhpsRReUec3AGW_EmMEaHWdIbWePYvt8l7WTnw8n3J8130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82364.RAQhpsRReUec3AGW_EmMEaHWdIbWePYvt8l7WTnw8n3J8130_provenance.
- NP869052.RAYZhGc3wTnomxzshPEN9q8pB0pl5vZO7i-MS6AcAipN8130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869052.RAYZhGc3wTnomxzshPEN9q8pB0pl5vZO7i-MS6AcAipN8130_provenance.
- assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP691109.RAAFWnuYSx3xmz8D1HSsEmGwulcrNcWFN4GqGUFgJzHQg130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691109.RAAFWnuYSx3xmz8D1HSsEmGwulcrNcWFN4GqGUFgJzHQg130_provenance.
- NP618856.RA_8tzxAF86yAWlPXcRgh9cgL6_NJb6oLmhQjaSSAqkJg130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618856.RA_8tzxAF86yAWlPXcRgh9cgL6_NJb6oLmhQjaSSAqkJg130_provenance.
- NP869428.RALnT858KxG9dO53mYfsgEV2IhE0VSmBV7V1wuSBbGwuU130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869428.RALnT858KxG9dO53mYfsgEV2IhE0VSmBV7V1wuSBbGwuU130_provenance.
- NP691110.RAF2OExoRPemcZTbA-SGuL6ZD8F35OkhPKzVbuk08SCzU130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691110.RAF2OExoRPemcZTbA-SGuL6ZD8F35OkhPKzVbuk08SCzU130_provenance.
- NP691107.RA1UpksRE0ujczdwzdoOWSy6dk8ge50WqN2-Xj2cVfJ-M130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691107.RA1UpksRE0ujczdwzdoOWSy6dk8ge50WqN2-Xj2cVfJ-M130_provenance.
- NP691108.RAzjVTLZSrIgErRjKYHR5X3O_BbhJrEC5Ybl4IDIzR_Q8130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691108.RAzjVTLZSrIgErRjKYHR5X3O_BbhJrEC5Ybl4IDIzR_Q8130_provenance.
- NP129449.RA-yHD4kQyiFR7O1a1-A6-R5mBxrBf3E6WqOWZVcDa23w130_assertion description "[ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129449.RA-yHD4kQyiFR7O1a1-A6-R5mBxrBf3E6WqOWZVcDa23w130_provenance.